BackTWi Biotechnology Overview

TWi Biotechnology Receivables

Latest receivables for 6610.TWO: $800K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$796000.00
↓ 14.13% YoYΔ $-131000.00 vs prior year quarter

Peer trimmed avg / median

Loading

TWi Biotechnology Receivables History

Loading

TWi Biotechnology vs. peers: Receivables Comparison

Loading

TWi Biotechnology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TWi Biotechnology (6610.TWO) FAQ

The latest receivables for 6610.TWO is $800K as of June 2026. That compares with $930K in the prior-year period — down 14.1% year over year. Investors often review this figure alongside TWi Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6610.TWO's receivables moved from $930K to $800K — a 14.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TWi Biotechnology's operating scale or balance-sheet position.

A receivables figure of $800K for 6610.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6610.TWO's receivables ($800K), review year-over-year change from $930K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack TWi Biotechnology's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.